Sunstone Metals (ASX:STM) is an ASX-listed mineral exploration company with two world-class gold and copper assets in Ecuador. Sunstone’s two porphyry projects are the Bramaderos Gold-Copper Project and the El Palmar Gold-Copper Project.
Copyright 2024 – Finance News Network
27 Apr 2020 - Kazia Therapeutics (ASX:KZA) CEO & MD, Dr. James Garner talks about its Phase II interim results for its glioblastoma drug candidate paxasilib, its pivotal GBM AGILE Phase II clinical study to commence 2H20 and value drivers as the company moves toward registration.
03 Dec 2019 - Synertec Corporation Limited (ASX:SOP) Managing Director, Michael Carroll & CFO, David Harris talk FY19 results, market conditions and the outlook for specialist engineering and compliance services.
11 Sep 2019 - BluGlass Limited (ASX:BLG) Managing Director Giles Bourne discusses partnering with LED lighting developer Bridgelux, enabling smaller and cheaper LEDs, and what the future holds with BLG’s new facility.
01 Mar 2021 - IVE Group Limited (ASX:IGL) Executive Chairman Geoff Selig talks about the company's strong 1H21 results on the back of a rebound in activity as the adverse impact of COVID disruptions diminishes.
21 Apr 2020 - Cashwerkz (ASX:CWZ) newly appointed CEO, Jon Lechte talks about what attracted him to the role, and plans to drive growth for cash and fixed income products in a more uncertain economic environment.
11 Jun 2020 - Brickworks Limited (ASX:BKW) Managing Director, Lindsay Partridge talks the company's expectations for growth in building materials, its property and investment portfolio in light of COVID-19 and how its diversified portfolio is its strength in times of uncertainty.
12 May 2021 - Galan Lithium (ASX:GLN) Managing Director Juan Pablo Vargas de la Vega provides an update on they company's key Hombre Muerto lithium brine project in the Catamarca province of Argentina.
20 Mar 2024 - PainChek Limited (ASX:PCK) CEO Philip Daffas provides an overview of the company, discussing its recent agreement with Nourish Care to expand into the UK market.
18 May 2022 - Chimeric Therapeutics Limited (ASX:CHM) CEO and Managing Director Jennifer Chow provides an update on clinical trial progression, and discusses recent agreements with WuXi Advanced Therapies and Be The Match BioTherapies.